Amicus Therapeutics
company in Cranbury, United States
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 7 annual filings
Revenue
$634.21M
Net Income
-$27.11M
Assets
$949.87M
EPS (diluted)
$-0.09
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession
0001178879-26-000005Amicus Therapeutics
Summary
Amicus Therapeutics is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (113 views/month).[2]
Key Facts
- Amicus Therapeutics is in the country of United States[3].
- Amicus Therapeutics is in the country of US[4].
- Amicus Therapeutics's instance of is recorded as business[5].
- Amicus Therapeutics's instance of is recorded as public company[6].
- Amicus Therapeutics's headquarters location is recorded as Cranbury[7].
- Amicus Therapeutics's headquarters location is recorded as Cranbury[8].
- Amicus Therapeutics's child organization or unit is recorded as Amicus Therapeutics ( United Kingdom)[9].
- Amicus Therapeutics's stock exchange is recorded as Nasdaq[10].
- Amicus Therapeutics's industry is recorded as pharmaceutical industry[11].
- 2002 marks the founding of Amicus Therapeutics[12].
- Amicus Therapeutics's official website is recorded as http://www.amicusrx.com[13].
- Amicus Therapeutics's product or material produced is recorded as biopharmaceutical[14].
- Amicus Therapeutics's legal form is recorded as Delaware corporation[15].
- Amicus Therapeutics's legal form is recorded as XTIQ[16].
Body
Founding
2002 marks the founding of Amicus Therapeutics[12].
Operations
Headquarters locations include Cranbury[7], a township of New Jersey[17], in United States[18]. Amicus Therapeutics's child organization or unit is recorded as it ( United Kingdom)[9].
Industry
Amicus Therapeutics's industry is recorded as pharmaceutical industry[11].
Ownership
Amicus Therapeutics's stock exchange is recorded as Nasdaq[10]. Its product or material produced is recorded as biopharmaceutical[14].
Why It Matters
Amicus Therapeutics ranks in the top 4% of business entities by monthly Wikipedia readership (113 views/month).[2]